查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1571679

蛋白質結合測定市場規模、佔有率、趨勢分析報告：按技術、按產品和服務、按最終用途、按地區、細分市場預測，2024-2030 年

Protein Binding Assays Market Size, Share & Trends Analysis Report By Technology (Ultrafiltration, Ultracentrifugation), By Product & Services (Instrument), By End Use (CROs), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

蛋白質結合測定市場成長與趨勢：

根據 Grand View Research, Inc. 的最新報告，預計到 2030 年，全球蛋白結合檢測市場規模將達到 8.963 億美元，2024 年至 2030 年複合年成長率為 10.2%。

蛋白質結合測定擴大應用於藥物發現和開發項目的臨床前階段。這些測定有助於檢測目標分子並提供有關治療劑和生技藥品特性的重要資訊。

製藥公司增加治療藥物開發的研發外包預計將增加蛋白質結合測定的採用。提供這些分子研究和分析服務的多家公司的存在預計將對預測期內的市場成長產生積極影響。

這些測定對於了解候選治療藥物的選擇和開發中的 ADME 特性非常有用。估計藥物開發過程中的安全裕度是一個重要的步驟，可以透過量化新化學物質與蛋白質的結合來完成。

蛋白質結合測定市場報告亮點

  • 2023年，市場佔有率。技術進步、策略性投資和不斷成長的消費者需求構成了市場成長。
  • 到 2023 年，平衡透析將佔據主導地位，佔有率為 49.7%。科學家和研究人員更喜歡這項技術，因為它成本低且準確度高。
  • 2023年，製藥和生物技術產業佔46.4%的佔有率。廣泛而強大的分銷網路以及對藥物發現的大量投資等因素正在推動該細分市場的成長。
  • 北美蛋白質結合檢測在 2023 年以 40.8% 的佔有率主導全球市場。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第 3 章蛋白質結合測定市場變數、趨勢與範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 蛋白質結合分析市場分析工具
    • 波特的分析
    • PESTEL分析

第4章 蛋白結合分析市場：產品和服務的估計和趨勢分析

  • 細分儀表板
  • 蛋白質結合分析市場：2023 年和 2030 年產品與服務變化分析
  • 裝置
  • 試劑套件和試劑
  • 服務

第5章 蛋白質結合檢測市場：技術評估與趨勢分析

  • 細分儀表板
  • 蛋白質結合分析市場：2023 年和 2030 年技術變化分析
  • 超速離心
  • 平衡透析
  • 超過濾
  • 表面等離子體共振
  • 其他

第6章蛋白質結合測定市場：最終用途估計與趨勢分析

  • 細分儀表板
  • 蛋白質結合分析市場：最終用途變異分析，2023 年和 2030 年
  • 受託研究機構
  • 製藥和生物技術公司
  • 其他

第7章蛋白質結合檢測市場：區域估計與趨勢分析

  • 2023 年和 2030 年蛋白質結合檢測市場佔有率（按地區）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 挪威
    • 丹麥
    • 瑞典
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特
    • 南非

第8章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Thermo Fisher Scientific
    • ADMEcell, Inc
    • Beckman Coulter, Inc
    • Sartorius Stedim BioOutsource Limited
    • Bio-Rad Laboratories, Inc
    • Abzena Ltd
    • Abcam Plc
    • GVK Biosciences Private Limited
    • Promega Corporation
    • Arryait Corporation
    • Charles River Laboratories
    • Sovicell
    • Eurofins Scientific
    • 3B Pharmaceuticals
    • Creative Biolabs
    • Evotec SE
    • BioDuro-Sundia
    • Merck KGaA
簡介目錄
Product Code: GVR-3-68038-593-9

Protein Binding Assays Market Growth & Trends:

The global protein binding assays market size is expected to reach USD 896.3 million by 2030 at a CAGR of 10.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. Protein binding assays are increasingly being adopted in preclinical stages of drug discovery & development programs. These assays help in detection of target molecules and provide critical information about the properties of therapeutics and biologics.

Increase in number of R&D outsourcing activities by pharmaceutical companies for development of therapeutics is anticipated to increase the adoption of protein binding assays. Presence of several companies that provide these services for molecule investigation and analysis is expected to positively impact the market growth over the forecast period.

These assays provide help understand ADME properties during selection and development of therapeutic candidates. Estimation of safety margins during drug development is an important step that can be carried out by quantification of binding of new chemical entities to a protein.

Protein Binding Assays Market Report Highlights:

  • The services segment dominated with a market share of 44.7% in 2023. Technological advancements, strategic investments, and increasing consumer demand constitute market growth.
  • The equilibrium dialysis dominated with a share of 49.7% in 2023. Scientists and researchers prefer this technique due to its low price and high accuracy.
  • The pharmaceuticals and biotechnology segment dominated with a 46.4% market share in 2023. Factors such as a wide and strong distribution network and significant investments in drug discovery boost the segment growth.
  • The North America protein binding assays dominated the global market with a share of 40.8% in 2023.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Protein Binding Assay Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Protein Binding Assay Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining Power of the Suppliers
      • 3.4.1.2. Bargaining Power of the Buyers
      • 3.4.1.3. Threats of Substitution
      • 3.4.1.4. Threats From New Entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political Landscape
      • 3.4.2.2. Economic and Social Landscape
      • 3.4.2.3. Technological Landscape
      • 3.4.2.4. Environmental Landscape
      • 3.4.2.5. Legal Landscape

Chapter 4. Protein Binding Assay Market: Product & Services Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Protein Binding Assay Market: Product & Services Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Instrument
    • 4.3.1. Instrument Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Kits & Reagents
    • 4.4.1. Kits & Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Services
    • 4.5.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Protein Binding Assay Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Protein Binding Assay Market: Technology Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Ultracentrifugation
    • 5.3.1. Ultracentrifugation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Equilibrium Dialysis
    • 5.4.1. Equilibrium Dialysis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Ultrafiltration
    • 5.5.1. Ultrafiltration Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Surface Plasmon Resonance
    • 5.6.1. Surface Plasmon Resonance Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Protein Binding Assay Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Protein Binding Assay Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Contract Research Organizations
    • 6.3.1. Contract Research Organizations Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Pharmaceutical & Biotechnology Companies
    • 6.4.1. Pharmaceutical & Biotechnology Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Protein Binding Assay Market: Regional Estimates & Trend Analysis

  • 7.1. Protein Binding Assay Market Share, By Region, 2023 & 2030 (USD Million)
  • 7.2. North America
    • 7.2.1. North America Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. France Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Spain
      • 7.3.5.1. Spain Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Italy
      • 7.3.6.1. Italy Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7. Norway
      • 7.3.7.1. Norway Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8. Denmark
      • 7.3.8.1. Denmark Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.9. Sweden
      • 7.3.9.1. Sweden Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. China
      • 7.4.2.1. China Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Japan Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. India Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Australia Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Thailand Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Saudi Arabia
      • 7.6.2.1. Saudi Arabia Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. UAE
      • 7.6.3.1. UAE Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. Kuwait
      • 7.6.4.1. Kuwait Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Africa
      • 7.6.5.1. South Africa Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. Thermo Fisher Scientific
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/ Strategic Initiatives
    • 8.4.2. ADMEcell, Inc
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/ Strategic Initiatives
    • 8.4.3. Beckman Coulter, Inc
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/ Strategic Initiatives
    • 8.4.4. Sartorius Stedim BioOutsource Limited
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/ Strategic Initiatives
    • 8.4.5. Bio-Rad Laboratories, Inc
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/ Strategic Initiatives
    • 8.4.6. Abzena Ltd
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/ Strategic Initiatives
    • 8.4.7. Abcam Plc
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/ Strategic Initiatives
    • 8.4.8. GVK Biosciences Private Limited
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/ Strategic Initiatives
    • 8.4.9. Promega Corporation
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/ Strategic Initiatives
    • 8.4.10. Arryait Corporation
      • 8.4.10.1. Participant's Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Recent Developments/ Strategic Initiatives
    • 8.4.11. Charles River Laboratories
      • 8.4.11.1. Participant's Overview
      • 8.4.11.2. Financial Performance
      • 8.4.11.3. Product Benchmarking
      • 8.4.11.4. Recent Developments/ Strategic Initiatives
    • 8.4.12. Sovicell
      • 8.4.12.1. Participant's Overview
      • 8.4.12.2. Financial Performance
      • 8.4.12.3. Product Benchmarking
      • 8.4.12.4. Recent Developments/ Strategic Initiatives
    • 8.4.13. Eurofins Scientific
      • 8.4.13.1. Participant's Overview
      • 8.4.13.2. Financial Performance
      • 8.4.13.3. Product Benchmarking
      • 8.4.13.4. Recent Developments/ Strategic Initiatives
    • 8.4.14. 3B Pharmaceuticals
      • 8.4.14.1. Participant's Overview
      • 8.4.14.2. Financial Performance
      • 8.4.14.3. Product Benchmarking
      • 8.4.14.4. Recent Developments/ Strategic Initiatives
    • 8.4.15. Creative Biolabs
      • 8.4.15.1. Participant's Overview
      • 8.4.15.2. Financial Performance
      • 8.4.15.3. Product Benchmarking
      • 8.4.15.4. Recent Developments/ Strategic Initiatives
    • 8.4.16. Evotec SE
      • 8.4.16.1. Participant's Overview
      • 8.4.16.2. Financial Performance
      • 8.4.16.3. Product Benchmarking
      • 8.4.16.4. Recent Developments/ Strategic Initiatives
    • 8.4.17. BioDuro-Sundia
      • 8.4.17.1. Participant's Overview
      • 8.4.17.2. Financial Performance
      • 8.4.17.3. Product Benchmarking
      • 8.4.17.4. Recent Developments/ Strategic Initiatives
    • 8.4.18. Merck KGaA
      • 8.4.18.1. Participant's Overview
      • 8.4.18.2. Financial Performance
      • 8.4.18.3. Product Benchmarking
      • 8.4.18.4. Recent Developments/ Strategic Initiatives